|
Heraeus distributes biomaterial Ostim®
ADC Advanced Dental Care, a subsidiary of aap Implantate AG, a German medical technology company active in the areas of fracture healing, joint replacement, bone cements and biomaterials, has entered into a long-term agreement with Heraeus Kulzer GmbH for the worldwide distribution of aap´s bone graft substitute Ostim® in the dental field. Heraeus Kulzer, a subsidiary of the Heraeus Group, is a leading European supplier of dental products.
Ostim® is a synthetic nanotechnology-based, absorbable bone graft substitute. Nanostructure, revascularization and bone transformation quality of Ostim® extensively corresponds to the quality of the natural bone.
This agreement, which significantly enlarges an existing cooperation, also includes the market introduction of Ostim® in the dental field in the USA. The FDA approval required for this has already been obtained. After a one-year introductory phase, the target minimum sales volume of the cooperation is significantly above one million Euros per year for ADC and should further increase in coming years.
In October 2005 aap Implantate AG acquired 54% of ADC´s shares.
For further information, please contact:
aap Implantate AG | | | Lorenzweg 5 | | | D-12099 Berlin | | | X | | | Oliver Bielenstein | Nanette Hüdepohl | | Director/CFO | Investor & Public Relations | Tel.: +49 30 750 19 - 140 | Tel.: +49 30 75019 - 133 | Fax: +49 30 750 19 - 290 | Fax: +49 30 75019 - 290 | | X | | | WKN 506660, ISIN DE0005066609 | | | Prime Standard/Regulated Market | | | Traded at all German Stock Exchanges |
|